Test COPE

Some of our Successes

COPE Software the lab automation software

Our Statistics

We have delivered excellent results in numerous projects using COPE, demonstrating its versatility and effectiveness in various areas. When will you seize this opportunity? 

Reduced personal costs:

84%

Reduced costs of operation resources:

20%

Higher throughput and reliable reproducibility:

69%

Overall cost
savings:

30%
Further information can be found on MDPI

Over ten years ago, a dedicated team at the Fraunhofer Institute for Production Technology IPT envisioned the dream of fully automating laboratories. As we began building our first automated platform, it became evident that no existing software could adequately monitor and control our processes and devices. This realization led us to develop our own software expertise, giving birth to our control software, COPE. Since then, much has changed. Today, COPE is a robust product offering a wide range of functionalities, including workflow management, scheduling, data analysis, and automated quality control, all within a user-friendly interface. We continue to innovate, with upcoming features like AI-optimized production for cell and gene therapies. Explore our projects to see how COPE has already been applied to several cutting-edge initiatives.

COPE Software
Development Timeline

2011 - First concept

Market need identification and basic architecture development

2017 - First project: Stem Cell Factory

Platform development and first prototype of the control software

2018 - Successful market entry

First successfully completed industrial projects

2021 - New design

COPE goes web-based frontend and rebranding

2022 - Integration of OPC UA

Connecting all devices and GAMP conformity

Some of our Projects

COPE has been successfully used in numerous projects and is now part of the most innovative ATMP productions. Explore our portfolio to learn more about how COPE has been implemented in these projects.
Create and execute protocols with ease using a no-code drag & drop editor.

Autostem

The AUTOSTEM project aims to create a closed, automated, GMP-ready pipeline for efficient clinical-grade MSC production. Using bioreactor-based, multiliter-scale production, the project has developed a robot-assisted platform that eliminates direct operator interaction with the product. COPE manages production process and ensures a reproducibly high and cell product quality.
2016/01 – 2018/12
View project
The StemCellFactory project aims to achieve automated generation and expansion of iPSCs along with automated genome editing.

StemCellFactory

The StemCellFactory project aims to achieve automated generation and expansion of iPSCs along with automated genome editing. With COPE, researchers can now parallel cultivate cells in 6/24/96-well-plates, enabling flexible and adaptive cultivation. Integrating a high-speed microscope for non-invasive and automated quality control, ensuring efficient and accurate analysis.
2017/07 – 2019/06
View project
automated lab management

JointPromise

The JointPromise project aims to achieve fully automated production of tissue-engineered joint implants for osteoarthritis by integrating bioreactors and 3D printers. COPE manages the production of personalized joint implants that meet stringent quality standards, ensuring better outcomes for patients.
2020/01 – 2025/06
View project
The AutoCrat project focuses on the parallelized bioreactor-based production of therapeutic cells.

AutoCrat

The AutoCrat project focuses on the parallelized bioreactor-based production of therapeutic cells. The project uses a modular approach to revolutionize R&D, production and quality control for induced pluripotent stem cells (iPSC), chondrocytes, mesenchymal stem cells (MSC) and extracellular vesicles. With GMP-compliant, robot-assisted production via COPE, AutoCRAT enhances efficiency in regenerative medicine manufacturing.
2020/01 – 2023/12
View project
The AIDPATH project, with the support of our control software COPE.

AIDPATH

The AIDPATH project, with the support of our control software COPE, aims to revolutionize the field of CAR-T-Cell therapy through AI-driven decentral production. in this project, COPE is an enabler for artificial intelligence to ensure AI-driven process optimization for efficient and optimized production workflows of CAR-T-Cells.
2021/01 – 2024/12
View project
lab controlling

RNAuto

The RNAuto project specializes in automating the production of mRNA-based therapies. It involves developing a no-code, modular screening platform to encapsulate mRNA into nano transporters. Our control software, COPE, digitalizes workflows and manages analytical devices and sensors, streamlining the process.
2022/01 – 2025/12
View project
Many of these activities in the laboratory of Stemcelldiscovery can be automated by Cope Software

StemCellDiscovery

Routine laboratory work is labor-intensive and usually requires qualified personnel with specialized know-how. However, many of these activities in the laboratory can be automated to increase reproducibility and throughput – and thus relieve the workload on skilled personnel.
since 2024/02
View project

Deep dive into our publications

Year

Titel

2024
A production scheduling and control system for CAR T cell manufacturing
2023
Digital transformation of CAR-T cell therapy – challenges and potential for Industry 4.0
2023
Elaborating the potential of Artificial Intelligence in automated CAR-T cell manufacturing
2022
Automation, Monitoring, and Standardization of Cell Product Manufacturing
2018
Service-oriented Communication and Control System Architecture for Dynamically Interconnected Assembly Systems
2018
Highly modular and generic control software for adaptive cell processing on automated production platforms

Test now and start experiencing COPE!

Start free trial
cell culture automation software
Fraunhofer IPT
Cope Software

COPE is your Fraunhofer solution.

Desktop Linkedin

Legal

Privacy policy

Imprint

Contact

cope@ipt.fraunhofer.de

+49 241 8904-327

© COPE 2024. All right reserved

Menü
Test COPE